Saluda Medical Announces Closing of $100 Million Financing
MINNEAPOLIS, Jan. 10, 2025 /PRNewswire/ — Saluda Medical, Inc., a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using a novel closed-loop, dose-control neuromodulation platform, today announced the closing of a $100 million financing. The…